MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.34
0.02 (6.66%)
▲
5d:
+5.76%
30d:
+13.39%
90d:
-31.47%
BUY
HIGH Confidence
Analysis Updated: Jun 16, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MDCX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MDCX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.34, which is considered slightly high relative to its 30-day fair value range of $0.30 to $0.35.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.40. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: MDCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.67 (+1670.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.40. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: MDCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.67 (+1670.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.30 -
$0.35
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.7%)
- BULLISH: Trading 1670.8% below Wall St target ($5.67)
Trading Range Analysis
30-Day Trading Range
$0.30 -
$0.35
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.29
Resistance Level
$0.40
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.82
Wall Street Target
$5.67
(+1670.8%)
Share & Embed Analysis
Last updated: June 16, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1216 | 61 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 55 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$254 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 63 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$221 | 62 BUY |
